Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Correction to: The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.

Hamedani AG, Pelak VS.

Curr Treat Options Neurol. 2019 Oct 4;21(10):52. doi: 10.1007/s11940-019-0594-x.

PMID:
31583476
2.

Co-occurrence of Convergence Insufficiency and Cognitive Impairment in Parkinsonian Disorders: A Pilot Study.

Holden SK, Van Dok E, Pelak VS.

Front Neurol. 2019 Aug 9;10:864. doi: 10.3389/fneur.2019.00864. eCollection 2019.

3.

The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.

Hamedani AG, Pelak VS.

Curr Treat Options Neurol. 2019 Jul 25;21(9):41. doi: 10.1007/s11940-019-0582-1. Review. Erratum in: Curr Treat Options Neurol. 2019 Oct 4;21(10):52.

PMID:
31342218
4.

Sialidosis Type 1 Without Cherry-Red Spot.

Bou Ghannam AS, Mehner LC, Pelak VS.

J Neuroophthalmol. 2019 Sep;39(3):388-390. doi: 10.1097/WNO.0000000000000773. No abstract available.

PMID:
31107347
5.

Deep capillary retinal ischemia and high-titer prothrombin-associated antiphospholipid antibodies: A case series of three patients.

Schofield JR, Palestine AG, Pelak V, Mathias MT.

Am J Ophthalmol Case Rep. 2019 Apr 2;14:105-109. doi: 10.1016/j.ajoc.2019.03.010. eCollection 2019 Jun.

6.

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings.

Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B.

Alzheimers Res Ther. 2019 Mar 13;11(1):23. doi: 10.1186/s13195-019-0476-1.

7.

Relative preservation of facial expression recognition in posterior cortical atrophy.

Pressman PS, Gola K, Shdo SM, Miller BL, Fredericks C, Mielke C, Pelak V, Rankin KP.

Neurology. 2019 Mar 5;92(10):e1064-e1071. doi: 10.1212/WNL.0000000000007075. Epub 2019 Feb 13.

PMID:
30760634
8.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

9.

Transient Daily Episodes of Vision Loss Due to Parkinson's Disease.

Pelak VS, Berman BD.

Neuroophthalmology. 2018 Jul 20;43(4):260-264. doi: 10.1080/01658107.2018.1494202. eCollection 2019 Aug.

10.

The Visual Snow Conference: May 5, 2018, University of California San Francisco.

Pelak VS.

J Neuroophthalmol. 2018 Sep;38(3):e17-e18. doi: 10.1097/WNO.0000000000000693. No abstract available.

PMID:
29985800
11.

Patient perceptions of visual, vestibular, and oculomotor deficits in people with Parkinson's disease.

Berliner JM, Kluger BM, Corcos DM, Pelak VS, Gisbert R, McRae C, Atkinson CC, Schenkman M.

Physiother Theory Pract. 2018 Jul 6:1-8. doi: 10.1080/09593985.2018.1492055. [Epub ahead of print]

PMID:
29979909
12.

Central Visual Oscillopsia: Case Report and Review of the Literature.

Jones W, Silkworth W, Dusto N, Pelak VS, Berliner J, Buard I, Kluger B.

Cogn Behav Neurol. 2018 Jun;31(2):86-95. doi: 10.1097/WNN.0000000000000151. Review.

PMID:
29927799
13.

Vision in Alzheimer's disease: a focus on the anterior afferent pathway.

Pelak VS, Hills W.

Neurodegener Dis Manag. 2018 Feb;8(1):49-67. doi: 10.2217/nmt-2017-0030. Epub 2018 Jan 23. Review.

PMID:
29359625
14.

Visual Snow: a Potential Cortical Hyperexcitability Syndrome.

Bou Ghannam A, Pelak VS.

Curr Treat Options Neurol. 2017 Mar;19(3):9. doi: 10.1007/s11940-017-0448-3. Review.

PMID:
28349350
15.

Optic Radiation Tractography and Visual Field Deficits in Laser Interstitial Thermal Therapy for Amygdalohippocampectomy in Patients with Mesial Temporal Lobe Epilepsy.

Yin D, Thompson JA, Drees C, Ojemann SG, Nagae L, Pelak VS, Abosch A.

Stereotact Funct Neurosurg. 2017;95(2):107-113. doi: 10.1159/000454866. Epub 2017 Mar 22.

16.

Consensus classification of posterior cortical atrophy.

Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Suárez González A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC; Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area.

Alzheimers Dement. 2017 Aug;13(8):870-884. doi: 10.1016/j.jalz.2017.01.014. Epub 2017 Mar 2.

17.

Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting.

Kumpe DA, Seinfeld J, Huang X, Mei Q, Case DE, Roark CD, Subramanian PS, Lind KE, Pelak VS, Bennett JL.

J Neurointerv Surg. 2017 Sep;9(9):867-874. doi: 10.1136/neurintsurg-2016-012810. Epub 2016 Nov 8.

PMID:
27935482
18.

Effects of Testosterone Therapy on Cognitive Function in Aging: A Systematic Review.

Hua JT, Hildreth KL, Pelak VS.

Cogn Behav Neurol. 2016 Sep;29(3):122-38. doi: 10.1097/WNN.0000000000000104. Review.

19.

Clinical and imaging clues to posterior cortical atrophy.

Pelak VS, Filley CM.

Neurol Clin Pract. 2015 Jun;5(3):270-271. doi: 10.1212/CPJ.0000000000000136. No abstract available.

20.

Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study.

Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS.

Dement Geriatr Cogn Dis Extra. 2015 Feb 20;5(1):51-63. doi: 10.1159/000371509. eCollection 2015 Jan-Apr.

21.

Nonarteritic anterior ischemic optic neuropathy in a child with optic disk drusen.

Nanji AA, Klein KS, Pelak VS, Repka MX.

J AAPOS. 2012 Apr;16(2):207-9. doi: 10.1016/j.jaapos.2011.10.016.

PMID:
22525184
22.

A preliminary study of functional abnormalities in aMCI subjects during different episodic memory tasks.

Jin M, Pelak VS, Curran T, Nandy RR, Cordes D.

Magn Reson Imaging. 2012 May;30(4):459-70. doi: 10.1016/j.mri.2011.12.014. Epub 2012 Mar 3.

23.

Dural sinus stent placement for idiopathic intracranial hypertension.

Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M.

J Neurosurg. 2012 Mar;116(3):538-48. doi: 10.3171/2011.10.JNS101410. Epub 2011 Dec 9.

PMID:
22149379
24.

Computerized visual field defects in posterior cortical atrophy.

Pelak VS, Smyth SF, Boyer PJ, Filley CM.

Neurology. 2011 Dec 13;77(24):2119-22. doi: 10.1212/WNL.0b013e31823e9f2a. Epub 2011 Nov 30.

PMID:
22131540
25.

Aberrant default mode network in subjects with amnestic mild cognitive impairment using resting-state functional MRI.

Jin M, Pelak VS, Cordes D.

Magn Reson Imaging. 2012 Jan;30(1):48-61. doi: 10.1016/j.mri.2011.07.007. Epub 2011 Oct 6.

26.

Ocular motility of aging and dementia.

Pelak VS.

Curr Neurol Neurosci Rep. 2010 Nov;10(6):440-7. doi: 10.1007/s11910-010-0137-z. Review.

PMID:
20697981
27.

Teaching neuroimages: Superior segmental optic nerve hypoplasia confirmed by optical coherence tomography.

Athappilly G, Pelak VS.

Neurology. 2009 May 5;72(18):e91-2. doi: 10.1212/WNL.0b013e3181a411f8. No abstract available.

PMID:
19414718
28.

Ischemic optic neuropathy.

Athappilly G, Pelak VS, Mandava N, Bennett JL.

Neurol Res. 2008 Oct;30(8):794-800. doi: 10.1179/174313208X319107. Review.

PMID:
18826805
29.

Stiff eyes in stiff-person syndrome.

Oskarsson B, Pelak V, Quan D, Hall D, Foster C, Galetta S.

Neurology. 2008 Jul 29;71(5):378-80. doi: 10.1212/01.wnl.0000319725.22925.b4. No abstract available.

PMID:
18663186
30.

Homonymous Hemianopia: A Critical Analysis of Optical Devices, Compensatory Training, and NovaVision.

Pelak VS, Dubin M, Whitney E.

Curr Treat Options Neurol. 2007 Jan;9(1):41-7.

PMID:
17288888
31.

Determining whether delayed nonarteritic ischemic optic neuropathy associated with cataract extraction is a true entity.

Nguyen LT, Taravella MJ, Pelak VS.

J Cataract Refract Surg. 2006 Dec;32(12):2105-9.

PMID:
17137991
32.

Spinal and cranial hypertrophic neuropathy in multiple sclerosis.

Quan D, Pelak V, Tanabe J, Durairaj V, Kleinschmidt-Demasters BK.

Muscle Nerve. 2005 Jun;31(6):772-9.

PMID:
15793846
33.

Neuro-ophthalmic manifestations of neurodegenerative disease.

Pelak VS, Hall DA.

Ophthalmol Clin North Am. 2004 Sep;17(3):311-20, v. Review.

PMID:
15337190
34.

Visual Hallucinations.

Pelak VS, Liu GT.

Curr Treat Options Neurol. 2004 Jan;6(1):75-83.

PMID:
14664772
35.

Diffusion-weighted magnetic resonance imaging and the evaluation of cortical blindness in preeclampsia.

Gregory DG, Pelak VS, Bennett JL.

Surv Ophthalmol. 2003 Nov-Dec;48(6):647-50.

PMID:
14609710
36.

Development of neurologic symptoms in a 26-year-old woman following recovery from methanol intoxication.

Fontenot AP, Pelak VS.

Chest. 2002 Oct;122(4):1436-9. No abstract available.

PMID:
12377876
37.

Ocular Myasthenia Gravis.

Pelak VS, Galetta SL.

Curr Treat Options Neurol. 2001 Jul;3(4):367-376.

PMID:
11389806
38.

Palsies of the third, fourth, and sixth cranial nerves.

Bennett JL, Pelak VS.

Ophthalmol Clin North Am. 2001 Mar;14(1):169-85, ix. Review.

PMID:
11370565
39.

New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis.

Balcer LJ, Baier ML, Pelak VS, Fox RJ, Shuwairi S, Galetta SL, Cutter GR, Maguire MG.

Mult Scler. 2000 Jun;6(3):163-71.

PMID:
10871827
40.

4.0 Tesla magnetic resonance imaging of brainstem lesions with ocular motility deficits.

Pelak VS, Bolinger L, Galetta SL, Butler N, Stein A, Liu GT.

J Neuroophthalmol. 2000 Jun;20(2):135-7.

PMID:
10870931
41.

Variation in in-patient stroke management in ten centres in different countries: the INCLEN multicentre stroke collaboration.

Heller R, O'Connell R, Lim L, Aggrawal A, Nogueira A, Alvares Salis LH, Jialiang W, Qian W, Kuaban C, Muna W, Khedr S, Prasad K, Joshi P, John KR, Mathai D, Roxas A, Donaldo M, Poungvarin N, Silberberg D, Pack A, Pelak V, Matenga J.

J Neurol Sci. 1999 Aug 1;167(1):11-5. Erratum in: J Neurol Sci 2000 Mar 1;174(1):78. Noguira A [corrected to Nogueira A].

PMID:
10500255
42.

Evidence for preganglionic pupillary involvement in superficial siderosis.

Pelak VS, Galetta SL, Grossman RI, Townsend JJ, Volpe NJ.

Neurology. 1999 Sep 22;53(5):1130-2.

PMID:
10496281
43.

Acute sensorimotor polyneuropathy with tonic pupils and an abduction deficit: an unusual presentation of polyarteritis nodosa.

Bennett JL, Pelak VA, Mourelatos Z, Bird S, Galetta SL.

Surv Ophthalmol. 1999 Jan-Feb;43(4):341-4.

PMID:
10025516
44.

Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cells.

Biassoni R, Ferrini S, Prigione I, Pelak VS, Sekaly RP, Long EO.

Scand J Immunol. 1991 Mar;33(3):247-52.

PMID:
1707180
45.

Projections from inferior temporal cortex to prefrontal cortex via the uncinate fascicle in rhesus monkeys.

Ungerleider LG, Gaffan D, Pelak VS.

Exp Brain Res. 1989;76(3):473-84.

PMID:
2792241

Supplemental Content

Support Center